MarketBrain

CRH holds guidance, names new director

The building-materials supplier left its 2025 Adjusted EBITDA target unchanged at $7.5 billion to $7.7 billion.

The building-materials supplier CRH Public (CRH) reaffirmed its full-year financial outlook and appointed a new board member, signaling continuity in its long-term growth strategy.

The June quarter was notable for the absence of any revision to the company’s 2025 guidance, even as it continues to execute on a multi-year capital plan unveiled last September. CRH had previously set Adjusted EBITDA targets of $7.5 billion to $7.7 billion for 2025 and introduced 2030 ambitions that include 7% to 9% average annual revenue growth and Adjusted EBITDA margins of 22% to 24%. Neither set of figures was updated in the latest release.

Results for the period were not disclosed, but historical context from the company’s Investor Day shows a decade of steady expansion. From 2014 to 2024, CRH delivered an 8% compound annual revenue growth rate, reaching $35.6 billion in 2024, while Adjusted EBITDA grew at a 15% CAGR to $6.9 billion. Margins expanded for the 11th consecutive year in 2024, ending at 19.5%.

The company’s growth investments are now taking priority. At its 2025 Investor Day, CRH allocated approximately 70% of its $40 billion financial capacity for 2026–2030 to growth initiatives, up from 55% in the prior five-year period. That shift includes an $8 billion capital-expenditure plan through 2028, aimed at expanding capacity in high-growth markets and improving operational efficiencies. The acquisition of Eco Material Technologies, completed in 2025, increased U.S. cementitious capacity by about 60%, though no integration update was provided.

Segment performance was last detailed at the Investor Day, when CRH reorganized its reporting structure. Americas Materials Solutions generated $16.2 billion in revenue and $7.1 billion in Adjusted EBITDA in 2024, while Americas Building Solutions and International Solutions each contributed $1.8 billion in Adjusted EBITDA on revenues of $6.9 billion and $12.3 billion, respectively. No updated segment figures were disclosed in the latest release.

Guidance remains unchanged. CRH continues to expect Adjusted EBITDA of $7.5 billion to $7.7 billion for 2025, and its 2030 targets—including free-cash-flow conversion above 100%—remain in place.

The company also announced that Tony Will will join its board of directors effective July 1, 2026. The appointment follows a leadership transition in the finance function earlier this year, when Aylwyn Bryan succeeded Nancy Buese as CFO.